With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
It's not the ideal motto for clinical trials. This editorial, as written by the NCI, sings praises to...the NCI, namely for complementing industry-sponsored trials by putting the human first. | Sharpless, JAMA 2019